Ocuvex Therap Company Profile
What is the competitive landscape for OCUVEX THERAP
OCUVEX THERAP has one approved drug.
There are thirteen US patents protecting OCUVEX THERAP drugs.
Drugs and US Patents for Ocuvex Therap
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ocuvex Therap | OMLONTI | omidenepag isopropyl | SOLUTION;OPHTHALMIC | 215092-001 | Sep 22, 2022 | RX | Yes | Yes | 10,765,750 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Ocuvex Therap | OMLONTI | omidenepag isopropyl | SOLUTION;OPHTHALMIC | 215092-001 | Sep 22, 2022 | RX | Yes | Yes | RE48183 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Ocuvex Therap | OMLONTI | omidenepag isopropyl | SOLUTION;OPHTHALMIC | 215092-001 | Sep 22, 2022 | RX | Yes | Yes | 12,290,511 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Ocuvex Therap | OMLONTI | omidenepag isopropyl | SOLUTION;OPHTHALMIC | 215092-001 | Sep 22, 2022 | RX | Yes | Yes | 8,648,097 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Ocuvex Therap | OMLONTI | omidenepag isopropyl | SOLUTION;OPHTHALMIC | 215092-001 | Sep 22, 2022 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Ocuvex Therap | OMLONTI | omidenepag isopropyl | SOLUTION;OPHTHALMIC | 215092-001 | Sep 22, 2022 | RX | Yes | Yes | 9,415,038 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| Ocuvex Therap | OMLONTI | omidenepag isopropyl | SOLUTION;OPHTHALMIC | 215092-001 | Sep 22, 2022 | RX | Yes | Yes | 12,295,946 | ⤷ Start Trial | Y | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Ocuvex Therap Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | WO2015105144 | ⤷ Start Trial |
| South Korea | 101824829 | ⤷ Start Trial |
| New Zealand | 721620 | ⤷ Start Trial |
| Philippines | 12016501357 | ⤷ Start Trial |
| Eurasian Patent Organization | 201691244 | ⤷ Start Trial |
| Japan | 5556924 | ⤷ Start Trial |
| Taiwan | 201609186 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

